Overview
Enkephalins are naturally occurring opioid peptides produced within the nervous system. Discovered in the 1970s as part of the family of endogenous opioids, they act as modulators of pain and affect multiple brain circuits. They are concentrated in regions involved in movement and reward, such as the basal ganglia, and contribute to the brain's intrinsic mechanisms for reducing pain.
Structure and biosynthesis
Chemically, enkephalins are short peptides made of five amino acids. Two common forms end with either methionine or leucine, and both begin with a tyrosine residue that is important for receptor binding. These small peptides are generated by enzymatic cleavage of larger precursor proteins, the result of post‑translational processing rather than direct ribosomal synthesis. Each active molecule consists of the characteristic five amino acids arranged in a specific sequence and exists briefly before being broken down by peptidases in the extracellular space of neuronal molecules.
Receptors and mechanism
Enkephalins act primarily on opioid receptors, where they produce inhibitory effects on neuronal signaling. Interaction with these receptors reduces neurotransmitter release and can dampen the perception of pain. Because they are peptides, enkephalins are rapidly inactivated by enzymes, which limits their duration of action and complicates their direct therapeutic use.
Physiological roles and distribution
Beyond analgesia, enkephalins play roles in regulating mood, stress responses and motor control. They are found in the brain, spinal cord and some peripheral tissues and are particularly abundant in pathways that process nociceptive (pain) information and in motor circuits of the basal ganglia.
Clinical and research relevance
Enkephalins have informed pain research and the development of drugs that target opioid receptors or slow peptide degradation. Because of rapid breakdown and limited ability to cross the blood–brain barrier, direct therapeutic use of native enkephalins is limited; current research explores stabilizing analogues and enzyme inhibitors to prolong their action. As endogenous opioids, enkephalins are also studied for their roles in addiction, mood disorders and neurodegenerative disease.
Distinctions and summary
Enkephalins are one subset of endogenous opioid peptides, distinct from longer endorphins and the dynorphin family. The two simple variants—methionine‑enkephalin and leucine‑enkephalin—illustrate how small changes in peptide sequence can influence receptor preference and function. As a natural neurotransmitter-modulating system, enkephalins remain a central topic in neuroscience and pain biology.